-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
For medical professionals only
Learn a hot search medicine every day
Type 2 diabetes ▍
indications [1-5]
suitable for diet control, Type 2 diabetes in
which neither exercise therapy nor weight loss adequately controls blood sugar.
Glimepiride tablets are not indicated for the treatment of type 1 diabetes (e.
g.
, treatment of diabetic patients with a history of ketoacidosis), diabetic ketoacidosis, or prediabetic coma or coma.
When the efficacy of this product decreases (partial secondary failure), this product can be combined with insulin
.
This product can also be combined with other oral hypoglycemic drugs such as non-β cells
.
▍Dosage [1-2].
- Tablets:
.
Starting dose and dose adjustment: the starting dose is 1 mg of glimepiride tablets
daily.
If necessary, the daily dose
can be increased.
Regular monitoring of blood glucose for dose adjustment is recommended, and it is recommended that the dose should be gradually increased, for example, every 1-2 weeks, gradually increasing the dose to 2 mg, 3 mg, 4 mg, 6 mg
daily.
Dose range for patients with well-controlled diabetes: for patients with well-controlled diabetes, the usual daily dose is 1 mg to 4 mg of glimepiride tablets
.
Daily doses greater than 6 mg are only more effective
in a small number of patients.
Dosing distribution: The timing and distribution
of dosing is determined based on the patient's current lifestyle.
It is recommended to take it immediately before breakfast, or immediately before the first meal if breakfast is skipped
.
- Capsule:
breakfast or at the first main meal.
Those patients who are sensitive to hypoglycemic agents should start with 1 mg once daily, and the dose
should be adjusted with caution.
There is no precise dose relationship
between glimepiride and other oral hypoglycemic agents.
The maximum initial dose of glimepiride does not exceed 2 mg
.
Usually maintenance dose: usually the maintenance dose is 1-4 mg once a day, and the recommended maximum maintenance dose is 6 mg once
a day.
After the dose reaches 2 mg, the dose is increased by no more than 2 mg
every 1-2 weeks, depending on the patient's blood glucose changes.
More popular drugs in Corey, where to learn?
You have just entered the department, where do you want to master the common drugs in Corey? In which cases do I need to adjust my dose? Should I double it for the first time? Whether the solvent is mixed with salt or sugar.
.
.
.
As a veteran of Corey, what is the difference between injections and tablets? What can be learned from foreign usage? How to deal with drug overdose? In the face of new recruits, how to elegantly throw a link to let Xiaobai learn medication knowledge?
The "evidence-based medicine" module of the dry drug decision assistant you want has 👇
1.
Scan the QR code
below 2.
Download the Clinical Decision Assistant App 3.
Open the Decision Assistant App
and click the icon
4.
Search for medicines
Download the App and check the hot search medicine every day!
Download the decision-making assistant App and check it anytime, anywhere~ References: [1] Drug information: glimepiride tablets, Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd.
,
Sinopharm H20073592
.
[2] Drug information: glimepiride capsules, Sichuan Pudu Pharmaceutical Factory, Sinopharm H20000704; 2007/07/09
。 [3] Drug information: glimepiride drop pills, Shandong New Times Pharmaceutical Co.
, Ltd.
, Sinopharm H20041773
.
[4] Drug information: glimepiride dispersible tablets, CSPC Ouyi Pharmaceutical Co.
, Ltd.
, 1mg: Sinopharm H20100183; 2mg: H20100182
.
[5] Drug information: glimepiride oral disintegration tablets, Wuhan Viao Pharmaceutical Co.
, Ltd.
, Sinopharm H20080704
.
Click "Read Original" for more dry medications